Physician Assistant · Mobile, AL
NPI
1639179898
Since 2005
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
580 Providence Park Dr E Fl 2
Mobile, AL, 36695
Phone (251) 631-3570
Groups this clinician bills Medicare through
Medicare paid, 2024
$202K
5,910 services
Medicare patients, 2024
717
Average age 75
Drug cost, 2024
$2.5M
2,666 prescriptions
Company payments, 2025
$3,825
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory A Sharp was code 17003 (destruction skin lesion), 2,592 times for 376 patients. In total Gregory A Sharp billed 5,910 services in 31 codes, and Medicare paid $202K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,592 | 376 | $3.68 | $9,539 |
| 99213 Office E&M - Established | Office | 856 | 545 | $47.39 | $41K |
| 17000 Destruction Skin Lesion | Office | 704 | 464 | $31.20 | $22K |
| 99214 Office E&M - Established | Office | 294 | 189 | $66.56 | $20K |
| 11102 Skin Biopsy | Office | 261 | 218 | $56.58 | $15K |
| 17004 Destruction Skin Lesion | Office | 82 | 65 | $81.78 | $6,706 |
| 99212 Office E&M - Established | Office | 53 | 48 | $31.73 | $1,682 |
| 11103 Skin Biopsy | Office | 49 | 35 | $30.48 | $1,493 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 38 | 19 | $0.60 | $22.95 |
| 96372 Injection Administration | Office | 34 | 19 | $7.99 | $272 |
| 99203 Office E&M - New | Office | 30 | 30 | $56.21 | $1,686 |
| 17110 Destruction Skin Lesion | Office | 27 | 23 | $62.36 | $1,684 |
| 11900 Skin | Office | 21 | 16 | $23.84 | $501 |
| 99204 Office E&M - New | Office | 17 | 17 | $68.97 | $1,172 |
| 99202 Office E&M - New | Office | 14 | 14 | $27.57 | $386 |
By year: 2022 $164K for 3,798 services; 2023 $232K for 5,859 services; 2024 $202K for 5,910 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gregory A Sharp prescribed most often to Medicare patients was Ketoconazole, with 567 prescriptions and refills. In total Gregory A Sharp wrote 2,666 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 567 | 582 | 251 | $11K |
| Clobetasol Propionate Generic | 347 | 354 | 189 | $17K |
| Triamcinolone Acetonide Generic | 264 | 289 | 167 | $4,034 |
| Doxycycline Hyclate Generic | 196 | 249 | 77 | $6,125 |
| Hydrocortisone Generic | 160 | 169 | 111 | $977 |
| Dupixent Pen Dupilumab | 88 | 88 | 13 | $353K |
| Minocycline Hcl Generic | 74 | 96 | 24 | $3,116 |
| Clindamycin Phosphate Generic | 69 | 77 | 33 | $2,852 |
| Imiquimod Generic | 64 | 76 | 47 | $2,347 |
| Mupirocin Generic | 54 | 54 | 43 | $393 |
| Hydroxyzine Hcl Generic | 54 | 75 | 13 | $518 |
| Terbinafine Hcl Generic | 53 | 78 | 25 | $606 |
| Tacrolimus Generic | 49 | 49 | 29 | $7,223 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 44 | 47 | 15 | $3,267 |
| Dupixent Syringe Dupilumab | 34 | 34 | Under 11 | $144K |
Brand drugs: 300 claims; generic drugs: 2,366 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory A Sharp $3,825 ($3,825 in general payments such as food, travel and fees) from 25 companies. The largest payer was Abbvie Inc. with $631.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 44 | $631 |
| Janssen Biotech, Inc. JNJ | 34 | $503 |
| UCB, Inc. UCB.BR | 19 | $394 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $390 |
| Incyte Corporation INCY | 20 | $305 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 22 | $291 |
| Lilly USA, LLC LLY | 12 | $196 |
| Genzyme Corporation SNY | 10 | $152 |
| LEO Pharma Inc. | 14 | $151 |
| Pfizer Inc. PFE | 11 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.